Clinical Trials Sponsored by Recoly N.V.

Total 1642 results

Galapagos NV

Completed

GLPG0492 Pharmacodynamics

Healthy

Belgium
Galapagos NV

Completed

Multiple Ascending Dose Study of GLPG0492 in Healthy Subjects

Healthy

Germany
Galapagos NV

Completed

Oral Bioavailability of GLPG0555 in Different Solid Formulations

Healthy

Belgium
Galapagos NV

Completed

GLPG0259 Solid Formulation Bioavailability and Food Effect

Healthy

Belgium
Fugeia NV

Completed

In Vivo Evaluation of the Physiological Effects of Arabinoxylan-oligosaccharides (AXOS) in Healthy Subjects (Adults)

Healthy

Belgium
Ecole des Hautes Etudes en Santé Publique

Completed

Pragmatic Randomised Controlled Trial Evaluating Effectiveness of a Smoking Cessation e- Intervention " Tabac Info Service "

Tobacco Smoking

France
McNeil AB
Janssen Pharmaceutica N.V., Belgium

Completed

A Study to Determine the Efficacy and Safety of a Benzocaine Lozenge for Treatment of Sore Throat.

Sore Throat

Russian Federation
Voronezh N.N. Burdenko State Medical Academy

Recruiting

Mast Cells and Its Proteases in COPD

COPD Exacerbation

Russian Federation
Enzyre B.V.
Indiana Hemophilia & Thrombosis Center

Not yet recruiting

Case and Use Scenario Study to Gain Knowledge on the User Needs for a Medical Device for Hemophilia A Monitoring

Hemophilia A

United States
SLAM Ortho B.V.
Erasmus Medical Center

Recruiting

Usability of the ADEPTH Sensor for Bore Depth Measurements in Plate Osteosynthesis Procedures (ADEPTH-Pilot)

Fractures, Bone | Osteosynthesis

Netherlands
University of Konstanz
Vivo international e.V.

Recruiting

Integration of Refugees Into Public Mental Health Care (INT_REF_MH)

Psychiatric Disorders From Chapters 3 and 4 of ICD10

Germany
Massachusetts General Hospital
Koa Health B.V.

Not yet recruiting

Waitlist-Control Trial of Smartphone CBT for Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Kinderkrankenhaus auf der Bult
SWEET e.V

Recruiting

Better Control in Pediatric and Adolescent diabeteS: Working to crEate CEnTers of Reference (SWEET- Registry) (SWEET)

Type 1 Diabetes

Germany
Intravacc B.V.
Novotech (Australia) Pty Limited

Completed

Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers (ITV2002)

COVID-19

Australia
Amsterdam UMC, location VUmc
MRIguidance B.V.

Completed

MRI-based Synthetic CT Images of the Head and Neck

Sinusitis | Hearing Loss | Head and Neck Tumor | Cholesteatoma | Imaging of Bony Structures of the Head (Various Conditions)

Netherlands
Massachusetts General Hospital
Koa Health B.V.

Completed

Therapist-Guided Smartphone-Delivered CBT for MDD

Major Depressive Disorder

United States
Massachusetts General Hospital
Koa Health B.V.

Withdrawn

Waitlist-Control Trial of Smartphone CBT for Social Anxiety Disorder (SAD)

Social Anxiety Disorder

United States
Wissenschaftliches Institut Bethanien e.V
Boehringer Ingelheim

Completed

Sleep Disorders in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Germany
FibroGen
AstraZeneca; Astellas Pharma Europe B.V.

Completed

Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis Participants (Himalayas)

Anemia in Incident Dialysis Patients

Russian Federation, Bulgaria, Thailand, United States, Argentina, Chile, Colombia, Korea, Republic of, Latvia, Malaysia, Mexico, Poland, Romania, Taiwan, Ukraine
FibroGen
AstraZeneca; Astellas Pharma Europe B.V.

Completed

A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis

CKD Anemia

United States, Australia, Thailand, Korea, Republic of, Malaysia, Mexico, Taiwan, New Zealand, Argentina, Chile, Colombia, Hong Kong, Peru, Philippines, Puerto Rico, Singapore
Koa Health B.V.
Massachusetts General Hospital

Active, not recruiting

Waitlist-Control Trial of Smartphone CBT for Body Dysmorphic Disorder (BDD)

Body Dysmorphic Disorders

United States
Wissenschaftliches Institut Bethanien e.V
Philips Respironics

Completed

Obesity in Sleep Medicine - Focusing on OHS Phenotypes

Obesity Hypoventilation Syndrome (OHS)

Germany
L.V. Prasad Eye Institute
Linkoeping University

Completed

Safety and Effectiveness of the RHCIII-MPC Biosynthetic Cornea in Patients Requiring Anterior Lamellar Keratoplasty

Leukoma

India
Bayer
Corporación Bonima S.A. de C.V.

Completed

Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Suspension

Anti-Infective Agents

Mexico
Aktion Bronchialkarzinom e.V.
Roche Pharma AG

Completed

Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab (INNOVATIONS)

Carcinoma, Non-Small-Cell Lung

Germany
G.V. (Sonny) Montgomery VA Medical Center

Unknown

Herpes Simplex Type 2 Co-infection in Veterans With Chronic Hepatitis C

Hepatitis C Virus Infection | Infection | Herpesvirus 2, Human

United States
University Hospital, Basel, Switzerland
Ricola Group AG Schweiz

Completed

Effectiveness of Different Candies Against Bad Breath (HALIDROP)

Bad Breath

Switzerland
Belgian Inflammatory Bowel Disease Research and...
Janssen Cilag N.V./S.A.

Recruiting

An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients With Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study (REScUE-OLE)

Crohn Disease

Belgium
Belgian Inflammatory Bowel Disease Research and...
Janssen Cilag N.V./S.A.

Active, not recruiting

Loss of RESponse to Ustekinumab Treated by Dose Escalation (REScUE)

Crohn Disease

Belgium
The University of Texas Health Science Center at...
Janssen Pharmaceutica N.V., Belgium

Completed

Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?

Schizophrenia | Schizoaffective

United States
University Hospital, Geneva
Ecole Polytechnique Fédérale de Lausanne

Recruiting

Telecytology as a Triage Tool in LMICs

Cervical Cancer

Switzerland
Ecole Polytechnique Fédérale de Lausanne
Nestle Health Science

Recruiting

Effect of Circadian Rhythm on Brain NAD Measured by Phosphorus Magnetic Resonance Spectroscopy at 7 Tesla (ChronoBrain)

Circadian Rhythm

Switzerland
Qompium NV

Recruiting

FibriCheck Data Registry (FDR)

Cardiac Arrhythmia

Belgium
Qompium NV

Recruiting

Fibricheck Detection cApabilities for Atrial Fibrillation (FDA-AF)

Atrial Fibrillation

United States, Belgium
Galapagos NV

Recruiting

A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis (GALARISSO)

Dermatomyositis

United States, Belgium, Italy, Chile, Spain, Poland, United Kingdom, Bulgaria, Romania, Colombia, Croatia, Czechia, France, Argentina
Oystershell NV

Recruiting

A Clinical Trial to Evaluate Efficacy and Safety of a New Suffocating Head Lice Product.

Head Lice | Pediculosis Capitis

United States
Galapagos NV

Active, not recruiting

A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis (OLINGUITO)

Axial Spondyloarthritis

Belgium, Korea, Republic of, Greece, Taiwan, France, Romania, Germany, Netherlands, Italy, Philippines, United Kingdom, Hungary, Estonia, South Africa, Bulgaria, Spain, Croatia, Czechia, Poland, Lithuania
Galapagos NV

Active, not recruiting

Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France (PARROTFISH)

Rheumatoid Arthritis

France
Oystershell NV

Completed

Safety and Efficacy of a Head Lice Shampoo

Head Lice

Germany
Oystershell NV

Completed

Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis

Onychomycosis of Toenail

Tunisia
Galapagos NV

Completed

Relative Bioavailability and Effect of Food Study With an Oral Mini-tablet Formulation of Filgotinib in Healthy Subjects

Bioavailability

Canada
Galapagos NV

Terminated

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS) (GLIDER)

Primary Sjögren Syndrome

Germany, Greece, Poland, Hungary, Ukraine
Galapagos NV

Terminated

A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Autosomal Dominant Polycystic Kidney Disease

Belgium, Netherlands, Italy, Spain, Czechia, Germany, Poland
Galapagos NV

Completed

Drug-drug Interaction Study With GLPG3667 and Itraconazole in Healthy Subjects

Healthy

Canada
Galapagos NV

Terminated

An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis.

Psoriatic Arthritis

Estonia, Belgium, Bulgaria, Czechia, Poland, Spain, Ukraine
Galapagos NV

Terminated

A Clinical Study to Test Long Term Safety of GLPG1690 for Patients With Systemic Sclerosis

Systemic Sclerosis

Spain, United States, Belgium, United Kingdom, Italy
Galapagos NV

Completed

A Study to Evaluate How Well Single and Multiple Doses of GLPG3667 Are Tolerated in Healthy, Adult Subjects

Healthy

Belgium
Galapagos NV

Completed

Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects

Healthy

Canada
Galapagos NV

Terminated

A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Erythematosus (TAPINOMA)

Systemic Lupus Erythematosus

Spain, Bulgaria, Moldova, Republic of, Poland, Ukraine
Galapagos NV

Completed

Drug-drug Interaction Study With GLPG3970 and Sulfasalazine in Adult, Healthy Subjects

Healthy

United States

Clinical Trials Sponsored by Recoly N.V.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations